BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25966013)

  • 1. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.
    Ghareeb M; Akhlaghi F
    Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
    Taylor PJ; Tai CH; Franklin ME; Pillans PI
    Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS for immunosuppressant therapeutic drug monitoring.
    Sallustio BC
    Bioanalysis; 2010 Jun; 2(6):1141-53. PubMed ID: 21083213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS application for therapeutic drug monitoring in alternative matrices.
    Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A
    J Pharm Biomed Anal; 2019 Mar; 166():40-51. PubMed ID: 30609393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
    Yang Z; Wang S
    J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
    Zhang Y; Zhang R
    Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
    Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
    Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.
    Aucella F; Lauriola V; Vecchione G; Tiscia GL; Grandone E
    J Pharm Biomed Anal; 2013 Dec; 86():123-6. PubMed ID: 23995754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry.
    Nguyen Thi MT; Capron A; Mourad M; Wallemacq P
    Clin Biochem; 2013 Dec; 46(18):1909-11. PubMed ID: 24060731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
    Pohanka A; Rosenborg S; Lindh JD; Beck O
    Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
    Saint-Marcoux F
    Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients.
    Laverdière I; Caron P; Couture F; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():131-7. PubMed ID: 22265668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring and LC-MS/MS.
    Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs.
    Velghe S; Stove CP
    Anal Bioanal Chem; 2018 Mar; 410(9):2331-2341. PubMed ID: 29362853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.
    Ivanova M; Artusi C; Polo G; Zaninotto M; Plebani M
    Clin Chem Lab Med; 2011 Jul; 49(7):1151-8. PubMed ID: 21574883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
    Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
    Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in antifungal drug measurement by liquid chromatography-mass spectrometry.
    Zheng YZ; Wang S
    Clin Chim Acta; 2019 Apr; 491():132-145. PubMed ID: 30685359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.